ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 285233 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 285233; 2) Community: the network communities that were significantly associated with the response to NSC 285233; 3) Molecule: the relationships between components within communities and NSC 285233; 4) MDR: the compounds that were significantly associated with the NSC 285233.

NSC Compound Enrichment Correlation
NSC 639498 Cyclopentanone, 2-[(dimethylamino)methyl]-5-(2-methyl- propylidene)-, hydrochloride 0.00397405528023196 0.62105226
NSC 652174 Null 0.00397405528023196 -0.050591315
NSC 657991 4H-Pyrazolo[3,4-d][1,3]thiazin-6-amine, 1-(2-hydroxybenzoyl)-4-(4-methoxyphenyl)-3-methyl- 0.00397405528023196 -0.038247074
NSC 658853 Null 0.00397405528023196 0.37053475
NSC 682689 2,4,16-Tribromoestra-1,3,5(10)-trien-3-ol-17-one 0.00397405528023196 0.28753382
NSC 248040 Null 0.00397405528023199 0.59956879
NSC 633271 Null 0.00433056621075587 0.38911441
NSC 665522 Null 0.00433056621075587 0.20212374
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.00433056621075589 0.80326876
NSC 681632 Camptothecin Derivative 0.00433056621075589 0.053153813
Total:62  Current:4    [First] [Prev] [Next] [Last]